Parry R - Search Results

1

Transfection of the mullerian inhibiting substance gene inhibits local and metastatic tumor-growth.

Boveri J, Parry R, Ruffin W, Gustafson M, Lee K, He W, Donahoe P. Boveri J, et al. Among authors: parry r. Int J Oncol. 1993 Feb;2(2):135-43. Int J Oncol. 1993. PMID: 21573527

2

Recombinant human mullerian inhibiting substance inhibits human ocular melanoma cell lines in vitro and in vivo.

Parry RL, Chin TW, Epstein J, Hudson PL, Powell DM, Donahoe PK. Parry RL, et al. Cancer Res. 1992 Mar 1;52(5):1182-6. Cancer Res. 1992. PMID: 1531323

3

Human müllerian inhibiting substance inhibits tumor growth in vitro and in vivo.

Chin TW, Parry RL, Donahoe PK. Chin TW, et al. Among authors: parry rl. Cancer Res. 1991 Apr 15;51(8):2101-6. Cancer Res. 1991. PMID: 2009529

4

Computer-aided cell colony counting.

Parry RL, Chin TW, Donahoe PK. Parry RL, et al. Biotechniques. 1991 Jun;10(6):772-4. Biotechniques. 1991. PMID: 1878212

5

Identification of a novel prostate tumor target, mindin/RG-1, for antibody-based radiotherapy of prostate cancer.

Parry R, Schneider D, Hudson D, Parkes D, Xuan JA, Newton A, Toy P, Lin R, Harkins R, Alicke B, Biroc S, Kretschmer PJ, Halks-Miller M, Klocker H, Zhu Y, Larsen B, Cobb RR, Bringmann P, Roth G, Lewis JS, Dinter H, Parry G. Parry R, et al. Among authors: parry g. Cancer Res. 2005 Sep 15;65(18):8397-405. doi: 10.1158/0008-5472.CAN-05-1203. Cancer Res. 2005. PMID: 16166318

6

Antibodies neutralizing hepsin protease activity do not impact cell growth but inhibit invasion of prostate and ovarian tumor cells in culture.

Xuan JA, Schneider D, Toy P, Lin R, Newton A, Zhu Y, Finster S, Vogel D, Mintzer B, Dinter H, Light D, Parry R, Polokoff M, Whitlow M, Wu Q, Parry G. Xuan JA, et al. Among authors: parry g, parry r. Cancer Res. 2006 Apr 1;66(7):3611-9. doi: 10.1158/0008-5472.CAN-05-2983. Cancer Res. 2006. PMID: 16585186

7

Targeting tomoregulin for radioimmunotherapy of prostate cancer.

Zhao XY, Schneider D, Biroc SL, Parry R, Alicke B, Toy P, Xuan JA, Sakamoto C, Wada K, Schulze M, Müller-Tiemann B, Parry G, Dinter H. Zhao XY, et al. Among authors: parry g, parry r. Cancer Res. 2005 Apr 1;65(7):2846-53. doi: 10.1158/0008-5472.CAN-04-4019. Cancer Res. 2005. PMID: 15805286

8

Hospital-acquired wound mucormycosis.

Paparello SF, Parry RL, MacGillivray DC, Brock N, Mayers DL. Paparello SF, et al. Among authors: parry rl. Clin Infect Dis. 1992 Jan;14(1):350-2. doi: 10.1093/clinids/14.1.350. Clin Infect Dis. 1992. PMID: 1571450

9

In vivo biodistribution, PET imaging, and tumor accumulation of 86Y- and 111In-antimindin/RG-1, engineered antibody fragments in LNCaP tumor-bearing nude mice.

Schneider DW, Heitner T, Alicke B, Light DR, McLean K, Satozawa N, Parry G, Yoo J, Lewis JS, Parry R. Schneider DW, et al. Among authors: parry g, parry r. J Nucl Med. 2009 Mar;50(3):435-43. doi: 10.2967/jnumed.108.055608. Epub 2009 Feb 17. J Nucl Med. 2009. PMID: 19223400 Free PMC article.

10

Autocrine TGFβ Is a Survival Factor for Monocytes and Drives Immunosuppressive Lineage Commitment.

Gonzalez-Junca A, Driscoll KE, Pellicciotta I, Du S, Lo CH, Roy R, Parry R, Tenvooren I, Marquez DM, Spitzer MH, Barcellos-Hoff MH. Gonzalez-Junca A, et al. Among authors: parry r. Cancer Immunol Res. 2019 Feb;7(2):306-320. doi: 10.1158/2326-6066.CIR-18-0310. Epub 2018 Dec 11. Cancer Immunol Res. 2019. PMID: 30538091 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

536 results

Search Page

Filters